Puma Biotechnology Inc

Despite the 280 percent year-to-date gains in Puma Biotechnology Inc (NASDAQ: PBYI) shares, Citigroup is projecting shares could go higher.  Citi maintained its Buy on Puma Biotechnology and raised its price target from $114 to $156. At the time of writing, shares of Puma Biotechnology were...